Patients who have run out of options don’t have time to wait for lengthy trials. But they also need treatments that offer proven benefit, and not just hope. Peter McIntyre asks whether we can speed [more]
Our systems for evaluating new therapies are only as good as the accuracy of the judgements we make about how far patients benefit and how far they feel the burden of side-effects and other drawbacks. [more]
The European Commission is developing a Europe-wide accreditation scheme for breast centres to push up standards of diagnosis and care. Here experts from both sides of the Atlantic take a look at existing schemes, the [more]
With health budgets flat-lining and demand for healthcare rising, the only way Europe can improve patient outcomes is by finding new ways to do things better. But who will champion innovation in cancer care and [more]
We wont improve cancer care until we know more about how well we are doing and how alternative approaches compare. It sounds obvious, but its not happening, says the real David Cameron Something in the [more]
The emotional and psychological impact of being diagnosed and treated for cancer can be at least as severe as the toll the disease and treatment takes on a patient’s physical health. Distress – the range [more]